| Financial Year |
March 31 2023 |
| Monetary Funds |
373,789,441.10 |
| Held-for-trading Financial Assets |
50,145,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
510,529,711.20 |
| Advances to Suppliers |
177,759,307.47 |
| Other Receivables |
4,624,582.38 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
493,468,604.08 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,984,198.62 |
| Total Current Assets |
1,723,828,011.31 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
52,574,882.86 |
| Investment Properties |
19,884,300.00 |
| Fixed Assetes |
404,109,116.62 |
| Under-construction Projects |
31,290,460.34 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
99,422,606.96 |
| R&D expenses |
-- |
| Goodwill |
530,133,894.64 |
| Long-Term Deferred and Prepaid Expenses |
10,357,248.79 |
| Deferred Income Tax Assets |
57,263,921.32 |
| Other Non-Current Assets |
706,000.00 |
| Sub-Total of Non-Current Assets |
1,223,239,808.69 |
| Total Assets |
2,947,067,820.00 |
| Short-Term Loans |
146,653,294.45 |
| Trading Financial liabilities |
-- |
| Notes Payable |
20,000,000.00 |
| Accounts Payable |
44,113,003.42 |
| Accounts Received In Advance |
211,121.02 |
| Employee Compensation Payable |
26,962,520.76 |
| Taxes Payable |
14,546,510.49 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,049,639.40 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,852,610.27 |
| Other Current Liabilities |
7,135,701.58 |
| Sub-Total of Current Liabilities |
309,249,370.71 |
| Long-term Loans |
-- |
| Bonds Payable |
201,722,953.16 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,534,967.61 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
216,320,349.51 |
| Total Liabilities |
525,569,720.22 |
| Paid-In Capital(Or Share Stock) |
206,564,695.00 |
| Capital Surplus |
1,389,948,474.87 |
| Surplus Reserve |
103,287,420.65 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
670,006,807.93 |
| Minority Stockholder's Interest |
2,594,077.43 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,418,904,022.35 |
| Owner's Equity（Stockholder's Equity） |
2,421,498,099.78 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,947,067,820.00 |
